PET-MRI brain scans for recent injury, stroke, or mild memory changes
Part of Brain & nervous system clinical trials.
This study uses special brain scans to measure proteins and connections in the brain after a recent injury, stroke, or in people with mild memory/behavior changes. The goal is to understand brain changes and how they relate to symptoms, which may help future diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 80 years old and able to judge for good overall health
- For healthy volunteers: no neurologic disorder and no cognitive problems (MMSE score 28 or higher)
- For recent TBI or recent stroke: your first episode was 1 to 4 weeks before enrolling
- For CTE: you have a recent CTE diagnosis (age 30 to 80) and are okay with amyloid scanning if not known
- For aMCI or MBI: you’re age 50 to 80 with a diagnosis of Alzheimer-related mild cognitive or behavior impairment, and you have (or will do) amyloid scanning
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new ultra-high resolution PET scanner to look at brain changes in healthy aging, dementia, ALS, movement disorders, and psychosis. It aims to better understand these conditions and improve imaging techniques.
This trial uses a special PET scan tracer to see if it can predict who will get worse over time. It is for people with mild memory or thinking problems that may be linked to past head injuries or early Alzheimer's disease.
This trial uses special brain scans (PET and MRI) to study chronic symptoms after a past traumatic brain injury (TBI), such as memory trouble, mood changes, and headaches. It may help researchers understand what’s going on in the brain and how it relates to symptoms like anxiety or distress.
This study uses special brain scans (PET scans) to look for proteins linked to Alzheimer's disease. It aims to improve diagnosis and track how the disease progresses over time.
This study uses a special PET brain scan to look at two types of brain immune cells in people with Alzheimer’s. It may help researchers better understand Alzheimer’s and how these cells change over time.
This trial uses advanced PET and MR scans to better understand and diagnose brain diseases like Alzheimer's, Parkinson's, epilepsy, and brain tumors. It may help identify new ways to track these conditions.
Hear when a new Neuro-Degenerative Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.